Indikationer for nuklearmedicinske undersøgelser ved prostatacancer

Andreas Underbjerg Raade, Karen Middelbo Buch-Olsen, Lars Lund, Helle D. Zacho, Michael Borre, Jorun Holm, Kasper Tholstrup Pedersen, Malene Grubbe Hildebrandt*

*Kontaktforfatter

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

4 Downloads (Pure)

Abstract

Nuclear medicine imaging for prostate cancer has advanced significantly over the past decade. A survey is presented in this review. PSMA-PET/CT is a new highly accurate method that has been introduced, but bone scans and bone-PET continue to be widely applied. PSMA-PET/CT still lacks sufficient patient outcome data to be recommended for treatment allocation when used for primary staging. However, the literature and clinical guidelines support its use at the stage of biochemical recurrence. In Denmark, the use of nuclear medicine examinations for prostate cancer aligns with clinical guideline recommendations.

Bidragets oversatte titelIndications for nuclear medicine imaging in prostate cancer
OriginalsprogDansk
ArtikelnummerV01240036
TidsskriftUgeskrift for Læger
Vol/bind186
Antal sider7
ISSN0041-5782
DOI
StatusUdgivet - 12 aug. 2024

Bibliografisk note

Published under Open Access CC-BY-NC-BD 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/.

Emneord

  • Humans
  • Male
  • Prostatic Neoplasms/diagnostic imaging
  • Positron Emission Tomography Computed Tomography
  • Bone Neoplasms/diagnostic imaging
  • Radiopharmaceuticals
  • Nuclear Medicine
  • Neoplasm Staging
  • Neoplasm Recurrence, Local/diagnostic imaging
  • Practice Guidelines as Topic

Fingeraftryk

Dyk ned i forskningsemnerne om 'Indikationer for nuklearmedicinske undersøgelser ved prostatacancer'. Sammen danner de et unikt fingeraftryk.

Citationsformater